PIRAMAL GROUP

Piramal Group is a global business conglomerate with interests in Pharma, Financial Services, Information Management, Glass Packaging and Real Estate. With offices in 30 countries and brand presence in over 100 markets, the Piramal Group has a global team of over 10,000 people from 21 diverse nationalities.

Since 1984, the Piramal Group has battled complex challenges to stay ahead of the curve. From one of the longest trade union strikes to fluctuating political stands, we have consistently attained organic and inorganic growth, thanks to strong global partnerships and strategic investments in core businesses. Today, the Piramal Group is valued at USD 9.5 billion, with more than 60% of the revenue generated from international markets. Our deal with Abbott in 2010, yielded a business evaluation of USD 3.72 billion – a staggering ~9x sale and ~30x EBITDA.

We believe in India’s economic potential and strive to transform the socio-economic ecosystems for a better tomorrow. Our philanthropic arm, Piramal Foundation runs innovative programmes across the healthcare, education, and water. Our initiatives such as Piramal Sarvajal and Swasthya are case studies at the Harvard Business School.

PIRAMAL PHARMA SOLUTIONS

Piramal Pharma Solutions is the Contract Development and Manufacturing arm of Piramal Enterprises Ltd., with operations across North America, Europe and Asia. We are a global leader in integrated solutions and offer a unique platform of services across the drug lifecycle – from drug discovery and development to commercial manufacturing of drug substances and drug products. Our capability as an integrated service provider & experience with various technologies enable us to serve innovator and generic companies worldwide.

With accreditations from regulatory bodies in US, Europe & Japan, our development centres and manufacturing sites across the globe have a pool of over 700 scientists committed to research & development programs.

At Piramal Pharma Solutions, our focus is on serving as a ‘Customer Centric’ organization. We accomplish this by keeping the “Pulse of the Customer” at the heart of our mission. We are constantly evolving our internal processes, communication and program management in order to continue to provide the best service to our clients.

We have been recognized by several global industry forums and have received awards for our quality, reliability, regulatory compliance and adherence to EHS guidelines.

Aurora, Canada

This is our site for development and GMP manufacturing for complex pharmaceutical NCEs. It is located in Aurora, 50 kms north of Toronto.

See Our Facility

Lexington, USA

The Coldstream Laboratories manufacturing facility utilizes isolator technology for aseptic processing in a 22,000 square foot state‐of‐the art building.

See Our Facility

Riverview, USA

Our State-of the-Art FDA licensed cGMP facility in Riverview, USA, has over 50 years of extensive experience in delivering robust cGMP manufacturing processes..

See Our Facility

Grangemouth, UK

Grangemouth, UK is a USFDA and MHRA approved site dedicated to the contract development and manufacturing of Antibody Drug Conjugates since 2004.

See Our Facility

Morpeth, UK

The Pharma Solutions Morpeth site is one-of-a-kind US FDA and UK MHRA approved facility offering integrated services across the pharmaceutical value chain.

See Our Facility

Ahmedabad, India

Ahmedabad, India site was established in 2009. It is a MPA, Sweden approved and FDA approvable facility for development..

See Our Facility

Ahmedabad, India

Piramal Discovery Solutions site is located in Ahmedabad, India and provides a comprehensive range of early stage drug discovery services

See Our Facility

Mumbai, India

Operational since 2005, our Mumbai site is fully equipped for development of all liquid dosage forms both Sterile and Non-sterile.

See Our Facility

Pithampur, India

The Pithampur formulations site is a Greenfield project set in 1992 by Piramal Pharma Solutions. The US FDA and UK MHRA approved facility..

See Our Facility

Ennore, India

Ennore is identified as the India centre for development and early phase projects located near the Chennai port. The site is spread over an area of 75 acres..

See Our Facility

Digwal, India

It is a dedicated and multipurpose plant identified for custom manufacturing and development for late phase API’s and advanced intermediates.

See Our Facility

Mahad, India

It is a multipurpose plant identified for manufacturing of straight Vitamins & Vitamin Mineral Premixes.

See Our Facility

Aurora, Canada

This is our site for development and GMP manufacturing for complex pharmaceutical NCEs. It is located in Aurora, 50 kms north of Toronto.

See Our Facility

Lexington, USA

The Coldstream Laboratories manufacturing facility utilizes isolator technology for aseptic processing in a 22,000 square foot state‐of‐the art building.

See Our Facility

SHANGHAI, CHINA

See Our Facility

OUR LOCATIONS

With a versatile, fully integrated network of development and manufacturing sites across North America, Europe, and Asia. Learn more about how we can serve your needs locally, wherever you are

Knowledge
Action
Care
Impact
 
1980s1990s2000s2010s2016s

1980 : Founded as a textiles business, Piramal Group shifted its focus to pharmaceuticals in the 1980s and over the course of the last three decades, Piramal Enterprises Ltd. (earlier Piramal Healthcare), under the leadership of Ajay Piramal and Dr. Swati Piramal, has become India’s fifth largest pharmaceutical company

1990 : Founded as a textiles business, Piramal Group shifted its focus to pharmaceuticals in the 1980s and over the course of the last three decades, Piramal Enterprises Ltd. (earlier Piramal Healthcare), under the leadership of Ajay Piramal and Dr. Swati Piramal, has become India’s fifth largest pharmaceutical company

2000 : Founded as a textiles business, Piramal Group shifted its focus to pharmaceuticals in the 1980s and over the course of the last three decades, Piramal Enterprises Ltd. (earlier Piramal Healthcare), under the leadership of Ajay Piramal and Dr. Swati Piramal, has become India’s fifth largest pharmaceutical company

2010 : Founded as a textiles business, Piramal Group shifted its focus to pharmaceuticals in the 1980s and over the course of the last three decades, Piramal Enterprises Ltd. (earlier Piramal Healthcare), under the leadership of Ajay Piramal and Dr. Swati Piramal, has become India’s fifth largest pharmaceutical company

2016 : Founded as a textiles business, Piramal Group shifted its focus to pharmaceuticals in the 1980s and over the course of the last three decades, Piramal Enterprises Ltd. (earlier Piramal Healthcare), under the leadership of Ajay Piramal and Dr. Swati Piramal, has become India’s fifth largest pharmaceutical company

Great!